Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.Co-treatment by docetaxel and vinblastine breaks down P-glycoprotein mediated chemo-resistance.Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.
P2860
Nanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@ast
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@en
type
label
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@ast
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@en
prefLabel
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@ast
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@en
P2093
P2860
P1476
Nanolipoparticles-mediated MDR ...... model of human breast cancer.
@en
P2093
Ali Badiee
Fatemeh Mosaffa
Hermann Lage
Javad Behravan
Khalil Abnous
Mahmoud Reza Jaafari
Mahnaz Nourbakhsh
P2860
P304
P577
2015-04-01T00:00:00Z